I haven't had any direct contact with doctors to ask them if they knew of CYDY, but it is not surprising that most in the medical professional only know the major drugs that have been touted (and failed or have been mildly useful at best).

It is doctors spreading awareness of leronlimab among themselves that we needed before, but now, I think that being so close to getting great clinical data from our COVID trials and the BLA for HIV having been filed and possible BTD for cancer, we won't need word of mouth any longer. In short order, "res ipse loquitor" as we say in the law, which means "the thing speaks for itself." And CYDY/leronlimab are ready to start screaming!